Pamela Esposito, Chief Business Officer: Replimune Group REPL Sell · Filed 23/08/24

Trade details

Type: Insider sale
Amount: $372,186
Shares · price: 18,600 sh · $20.01 a share
Held after: 263,436 sh
Stock: Replimune Group REPL
Person: Pamela EspositoChief Business Officer
Trade date: 23/08/22
Filed: 23/08/24
Days to filing: 2 days

Sold 6.6% of holdings

Share of holding sold: 6.6%

Replimune Group trades, last 26 weeks

What else happened in Replimune Group around then

Filed or reported within 30 days of the trade day · 23/07/23~23/09/21

Pamela Esposito's recent trades

Pamela EspositoDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$95.9K
1,200 sh
$95.9K
Filed 03/20
Traded 03/20
Pamela EspositoDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$54.4K
700 sh
$54.4K
Filed 03/20
Traded 03/20
Pamela EspositoDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$47.5K
600 sh
$47.5K
Filed 03/20
Traded 03/20
Pamela EspositoDirector
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$198.9K
2,500 sh
$198.9K
Filed 03/20
Traded 03/20
Pamela EspositoDirector
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$165.4K
1,900 sh
$165.4K
Filed 02/20
Traded 02/20

Pamela Esposito, Chief Officer — sold $372.2K of Replimune Group REPL · 6.6% of holdings · 10b5-1 plan | Whalegun